publication date: Feb. 21, 2014


NCI’s John Czajkowski Takes Executive Dean Position At Harvard Medical School

JOHN CZAJKOWSKI, NCI deputy director for management, has accepted a position as executive dean of administration at Harvard Medical School. His start date will be June 2.

“Needless to say, this has been a tough decision,” Czajkowski wrote in an email to NCI staff. “I care deeply about this organization, and I have the deepest respect for all of you as my colleagues. But the Executive Dean position presents a great opportunity for me and my family, and we ultimately decided that it is something we should pursue.”

was named the inaugural recipient of the Laura F. Hutchins, M.D. Distinguished Chair for Hematology and Oncology at the University of Arkansas for Medical Sciences.

Makhoul is director of the Division of Hematology/Oncology in the UAMS Winthrop P. Rockefeller Cancer Institute. Hutchins holds the Virginia Clinton Kelley Endowed Chair for Clinical Breast Cancer Research. She is a professor of medicine in the Division of Hematology/Oncology, where she served as division director from 1998 until September 2013.

“I cannot think of anyone better suited to hold the distinguished chair honoring Dr. Hutchins than her long-time colleague Dr. Makhoul,” said UAMS Chancellor Dan Rahn.

Funding for the chair was made possible by a donation of $1 million from an anonymous donor, proceeds from the institute’s 2012 Gala for Life fundraiser, and private donations. The chair holder uses the interest proceeds for research, teaching, or service activities.

Makhoul’s research focuses on the role on antiangiogenic therapy and targeting cancer-initiating cells in breast cancer, as well … Continue reading 40-08 In Brief

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.